NCT06933875 · Yale University
Promoting Palliative Care for People With Heart Failure
(P3HF)
What this study is about
This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care.
View original scientific description
This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care. Thus, this research may lead to improved care-concordant and goal-directed care for people with heart failure.
Interventions
BEHAVIORAL
Clinical Decision Support Tool
Deliver prognostic information and evidence-based decision support at the point of care
Primary outcome measures
Mean System Usability Scale score
Time frame: up to 15 months
System Usability Scale, 10-item Likert questionnaire. Total score range 0-100. Higher values indicate higher usability
Mean Acceptability of Intervention Measure score
Time frame: up to 15 months
Acceptability of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher acceptability.
Mean Appropriateness of Intervention Measure score
Time frame: up to 15 months
Appropriateness of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher appropriateness.
Mean Feasibility of Intervention Measure score
Time frame: up to 15 months
Feasibility of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher feasibility.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Healthcare providers must meet the following criteria:
- Are an attending physician, fellow, or resident, advanced practice nurse, or physician associate
- Has ordering privileges
- Are members of one of the hospitals' admitting teams (e.g., hospitalist service, cardiology service)
- Anticipate employment at one of the two study sites for the 15-month trial period. Or
- Palliative care team member
- Hospital administrator/quality and safety personnel Patients of providers enrolled in the study must meet the following criteria for heart failure during hospitalization:
- Age 18 years of age or older
- N-terminal pro-B-type natriuretic peptide values of \>500 pg/ml
- Received intravenous diuretics within 24 hours of admission.
Exclusion criteria
- Pregnant at the time of admission.
Where
- New Haven, Connecticut
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jul 16, 2026 · Source of record for eligibility and locations